首页> 外国专利> USE OF DEXTROMETHORPHAN AND OXIDASE INHIBITOR FOR REMOVING ADDICTION TO NARCOTICS AND ANTIDEPRESSANTS IN PATIENTS

USE OF DEXTROMETHORPHAN AND OXIDASE INHIBITOR FOR REMOVING ADDICTION TO NARCOTICS AND ANTIDEPRESSANTS IN PATIENTS

机译：使用右旋苯丙氨酸和氧化酶抑制剂消除患者对麻醉药和抗抑郁药的依赖

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine, narcology, biochemistry, pharmacy.;SUBSTANCE: invention proposes using the combination of dextromethorphan and the second medicine (quinidine, yohimbin, haloperdol, adjmaline, lobeline, pipamperon, fluoxetine, labetalol, chlorpromazine, domperidone, nortryptiline, quinine, oxyprenolol, propranolol, timolol, methaprolol, diphenhydramine, papaverine, mexiletine or their salts or isomers) for removing addiction to opiates, opioids or synthetic narcotics with exception cocaine and barbiturates (help in refusal in their using) or in case of chronic using antidepressant and corresponding treatment methods. The proposed combination of drugs reduces pain and relieves the withdrawal syndrome on the background of reducing morphine dose (antidepressant) up to the complete removing their intake.;EFFECT: enhanced effectiveness and valuable medicinal properties of medicine combinations.;54 cl, 2 ex

机译：领域：医学，麻醉学，生物化学，药学。物质：本发明提出结合使用右美沙芬和第二种药物（奎尼丁，育亨宾，氟哌啶，阿杰玛琳，洛贝林，匹帕龙，氟西汀，拉贝洛尔，氯丙嗪，多潘立酮，去甲炔诺明，奎宁，普萘洛尔，噻吗洛尔，美普洛尔，苯海拉明，罂粟碱，美西律或其盐或异构体），以消除对阿片类药物，阿片类药物或合成麻醉药的依赖（可卡因和巴比妥类药物除外（有助于拒绝使用））或在长期使用抗抑郁药和相应药物的情况下治疗方法。拟议中的药物组合可在减少吗啡剂量（抗抑郁药）直至完全消除其摄入的背景下减轻疼痛并缓解戒断综合征。;效果：增强药物组合的有效性和有价值的药物特性; 54 cl，2 ex

著录项

公开/公告号RU2281771C2

专利类型
公开/公告日2006-08-20

原文格式PDF
申请/专利权人 SMIT RICHARD ALEHN;
展开▼

申请/专利号RU20020115659
发明设计人 SMIT RICHARD ALEHN (US);
展开▼

申请日2000-12-22
分类号A61K31/485;A61K31/49;A61K31/4515;A61K31/439;A61K31/138;A61K31/5415;A61K31/137;A61K31/4709;A61K31/475;A61K31/4748;A61K31/4545;A61K31/166;A61K31/454;A61K31/472;A61P25/30;
国家 RU
入库时间 2022-08-21 21:21:34

相似文献

专利
外文文献
中文文献